HOOKIPA Pharma Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 19.68 million compared to USD 17.97 million a year ago. Basic loss per share from continuing operations was USD 0.27 compared to USD 0.4 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.859 USD | +5.35% | +12.10% | +6.05% |
May. 09 | HOOKIPA Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 25 | Transcript : HOOKIPA Pharma Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.05% | 80.68M | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- HOOK Stock
- News HOOKIPA Pharma Inc.
- HOOKIPA Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023